Stock listing
NYSE:ALC Alcon AG Stock
US listing (NYSE) of Alcon AG · home listing SIX Swiss:ALC
Follow Alcon AG into a list and get an email when it puts out news.
Share price · NYSE:ALC
$74.31 USD -0.95 (-1.3%)
Close on Nov 20, 2026
- Day range
- $74.10 – $75.04 USDNov 20, 2026
- Volume
- 3.42M sharesNov 20, 2026
- Market cap
- $35.92B USDAt the close on Nov 20, 2026 · price × 483.4M shares outstanding
- 52-week range
- $61.84 – $87.64 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $136.2M USDMedian day 1.66M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:ALC · Home | 62.28 CHF | -0.04 (-0.1%) | 1,581,462 | 62.72 | 62.98 | 62.24 | 62.32 | Close on Nov 20, 2026 |
| NYSE:ALC | $74.31 USD | -0.95 (-1.3%) | 3,421,088 | $74.17 | $75.04 | $74.10 | $75.26 | Close on Nov 20, 2026 |
| Xetra:2U3 | €67.70 EUR | -0.68 (-1.0%) | 2,146 | €67.70 | €68.10 | €67.70 | €68.38 | Close on Nov 20, 2026 |
| Stuttgart:2U3 | €67.58 EUR | -0.44 (-0.6%) | — | €67.40 | €68.14 | €67.20 | €68.02 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:ALC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $74.31 | -0.95 | -1.3% | $74.17 | $75.04 | $74.10 | 3,421,088 | |
| $75.26 | +1.15 | +1.6% | $73.41 | $75.52 | $73.35 | 4,740,683 | |
| $74.11 | +0.47 | +0.6% | $73.41 | $74.54 | $73.37 | 4,758,318 | |
| $73.64 | -0.48 | -0.6% | $74.35 | $74.76 | $73.50 | 1,768,781 | |
| $74.12 | +2.29 | +3.2% | $72.97 | $74.18 | $72.58 | 2,787,187 | |
| $71.83 | -0.63 | -0.9% | $73.06 | $73.95 | $71.64 | 2,251,919 | |
| $72.46 | -1.60 | -2.2% | $71.70 | $72.54 | $70.34 | 4,864,062 | |
| $74.06 | -1.08 | -1.4% | $74.72 | $75.71 | $72.21 | 5,157,077 | |
| $75.14 | +0.20 | +0.3% | $74.62 | $75.49 | $74.28 | 2,811,657 | |
| $74.94 | -1.61 | -2.1% | $74.24 | $75.23 | $74.01 | 3,123,891 | |
| $76.55 | -0.76 | -1.0% | $77.17 | $77.80 | $76.19 | 2,633,097 | |
| $77.31 | +4.94 | +6.8% | $75.70 | $77.85 | $75.58 | 3,748,835 | |
| $72.37 | -1.26 | -1.7% | $73.04 | $73.24 | $72.35 | 1,874,756 | |
| $73.63 | +2.18 | +3.1% | $72.06 | $74.19 | $72.05 | 2,199,172 | |
| $71.45 | +0.32 | +0.4% | $72.34 | $72.72 | $71.27 | 1,606,400 | |
| $71.13 | +1.30 | +1.9% | $70.44 | $71.35 | $70.39 | 1,255,400 | |
| $69.83 | +0.41 | +0.6% | $68.88 | $70.08 | $68.82 | 1,086,900 | |
| $69.42 | -0.57 | -0.8% | $69.58 | $70.02 | $69.30 | 1,198,200 | |
| $69.99 | -0.18 | -0.3% | $70.08 | $70.45 | $69.70 | 1,463,400 | |
| $70.17 | -0.46 | -0.7% | $70.16 | $70.46 | $69.54 | 2,592,400 | |
| $70.63 | +3.20 | +4.7% | $68.02 | $70.68 | $67.96 | 2,207,700 | |
| $67.43 | -0.40 | -0.6% | $67.56 | $68.09 | $67.09 | 1,103,700 | |
| $67.83 | +1.70 | +2.6% | $67.39 | $67.91 | $67.11 | 978,600 | |
| $66.13 | -0.05 | -0.1% | $65.50 | $66.16 | $65.44 | 1,100,000 | |
| $66.18 | -0.40 | -0.6% | $66.95 | $67.02 | $66.04 | 1,454,000 | |
| $66.58 | +2.71 | +4.2% | $65.44 | $66.79 | $65.02 | 2,399,500 | |
| $63.87 | +0.87 | +1.4% | $63.93 | $64.13 | $63.17 | 1,718,400 | |
| $63.00 | -1.35 | -2.1% | $63.91 | $64.19 | $62.10 | 2,503,000 | |
| $64.35 | +0.24 | +0.4% | $64.28 | $64.52 | $63.83 | 1,843,600 | |
| $64.11 | +0.98 | +1.6% | $63.87 | $64.20 | $63.53 | 1,346,000 | |
| $63.13 | +0.13 | +0.2% | $62.49 | $63.30 | $62.43 | 1,191,000 | |
| $63.00 | -0.19 | -0.3% | $63.36 | $63.69 | $62.94 | 1,544,300 | |
| $63.19 | -1.14 | -1.8% | $64.16 | $64.19 | $62.99 | 2,391,000 | |
| $64.33 | +0.57 | +0.9% | $63.65 | $64.35 | $63.55 | 1,375,900 | |
| $63.76 | -0.18 | -0.3% | $64.39 | $64.42 | $63.50 | 1,274,300 | |
| $63.94 | -0.81 | -1.3% | $64.64 | $64.82 | $63.40 | 2,216,000 | |
| $64.75 | -0.69 | -1.1% | $65.26 | $65.28 | $64.51 | 1,603,800 | |
| $65.44 | +0.18 | +0.3% | $65.50 | $65.52 | $64.73 | 2,288,500 | |
| $65.26 | +0.79 | +1.2% | $65.01 | $65.45 | $64.36 | 2,320,400 | |
| $64.47 | -0.09 | -0.1% | $64.02 | $64.70 | $64.02 | 2,457,900 | |
| $64.56 | -0.83 | -1.3% | $65.07 | $65.38 | $64.24 | 1,740,200 | |
| $65.39 | -0.20 | -0.3% | $65.15 | $65.71 | $65.06 | 1,054,000 | |
| $65.59 | +0.72 | +1.1% | $65.40 | $65.75 | $64.98 | 947,700 | |
| $64.87 | -0.17 | -0.3% | $65.83 | $65.83 | $64.85 | 1,315,200 | |
| $65.04 | -0.14 | -0.2% | $64.75 | $65.60 | $64.54 | 3,461,400 | |
| $65.18 | -1.12 | -1.7% | $66.27 | $66.28 | $64.70 | 2,136,300 | |
| $66.30 | -1.46 | -2.2% | $67.19 | $67.55 | $66.13 | 1,709,300 | |
| $67.76 | +0.02 | 0.0% | $67.06 | $67.94 | $66.95 | 1,507,960 | |
| $67.74 | +1.71 | +2.6% | $67.31 | $67.79 | $66.64 | 1,868,287 | |
| $66.03 | -0.52 | -0.8% | $67.26 | $67.42 | $65.94 | 1,942,100 | |
| $66.55 | -1.88 | -2.7% | $67.42 | $67.70 | $66.53 | 1,573,400 | |
| $68.43 | -0.69 | -1.0% | $68.90 | $69.37 | $68.26 | 1,964,800 | |
| $69.12 | -1.38 | -2.0% | $69.64 | $69.64 | $68.86 | 1,657,400 | |
| $70.50 | -1.58 | -2.2% | $70.89 | $71.14 | $70.48 | 1,341,000 | |
| $72.08 | -0.16 | -0.2% | $72.82 | $73.22 | $71.20 | 950,500 | |
| $72.24 | +0.49 | +0.7% | $71.72 | $73.52 | $71.72 | 1,328,000 | |
| $71.75 | -0.31 | -0.4% | $72.56 | $72.59 | $71.38 | 1,405,000 | |
| $72.06 | +0.05 | +0.1% | $71.89 | $72.45 | $71.39 | 1,106,700 | |
| $72.01 | -0.22 | -0.3% | $71.69 | $72.07 | $71.38 | 1,177,000 | |
| $72.23 | -0.44 | -0.6% | $72.46 | $72.82 | $72.16 | 716,520 | |
| $72.67 | -0.70 | -1.0% | $72.85 | $73.11 | $72.59 | 772,200 | |
| $73.37 | -0.33 | -0.4% | $73.35 | $73.43 | $72.70 | 816,200 | |
| $73.70 | +0.07 | +0.1% | $73.34 | $73.91 | $73.21 | 1,159,800 | |
| $73.63 | +0.70 | +1.0% | $72.80 | $73.84 | $72.64 | 994,200 | |
| $72.93 | -1.33 | -1.8% | $74.46 | $74.68 | $72.87 | 1,503,800 |
- Ticker
- NYSE:ALC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Sep 28, 2026
Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
Latest earnings call · Aug 11, 2026
Alcon (SIX Swiss: ALC) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
Q3 2026 Earnings Presentation
Earnings · 31 slides
Latest news
Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
Sep 28, 2026
Closed $65.26 (+1.2%) on Sep 28, 2026
Clareon PanOptix Pro and the UNITY Platform Lead Alcon's Surgical Innovations at ESCRS 2026
Sep 8, 2026
Closed $69.12 (-2.0%) on Sep 8, 2026
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
Sep 3, 2026
Closed $72.08 (-0.2%) on Sep 3, 2026
Alcon Prices EUR 500 Million Senior Notes Offering
Aug 26, 2026
Closed $72.23 (-0.6%) on Aug 27, 2026
Second-Quarter 2026 Earnings Call Regulatory Filing
Aug 11, 2026
Closed $75.35 (+2.3%) on Aug 11, 2026
Earnings Document (Q2 2026 Press Release)
Aug 10, 2026
Closed $75.35 (+2.3%) on Aug 11, 2026
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India
Jul 24, 2026
Closed $67.91 (+1.0%) on Jul 24, 2026
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada
Jun 15, 2026
Closed $66.29 (-0.8%) on Jun 15, 2026
2026 Annual General Meeting Minutes from Meeting
May 16, 2026
Closed $65.97 (+3.7%) on May 18, 2026
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
May 5, 2026
Closed $65.41 (-12.1%) on May 6, 2026
Alcon AG on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 31 in the last 12 months · 55 in all · newest Sep 28, 2026 · oldest 2025
- Calls
- 29 calls with a replay · 29 with a transcript · latest Aug 11, 2026
- Decks
- 93 decks · latest Nov 10, 2026
Where Alcon AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:ALC · Home listing | SIX Swiss | Switzerland | CHF |
| NYSE:ALC · This page | NYSE | United States | USD |
| LSIN:0A0D | LSIN | United Kingdom | CHF |
| Milan:1ALC | Milan | Italy | EUR |
| gettex:2U3 | gettex | Germany | EUR |
| Xetra:2U3 | Xetra | Germany | EUR |
| Lang & Schwarz:A2PDXE | Lang & Schwarz | Germany | EUR |
| Tradegate:2U3 | Tradegate | Germany | EUR |
| SIX Swiss:ALCE | SIX Swiss | Switzerland | CHF |
| LS Exchange:A2PDXE | LS Exchange | Germany | EUR |
| BX Swiss:2U3 | BX Swiss | Switzerland | CHF |
| B3:A2LC34 | B3 | Brazil | BRL |
| Frankfurt:2U3 | Frankfurt | Germany | EUR |
| Aquis:ALCZ | Aquis | United Kingdom | CHF |
| BMV:ALCN | BMV | Mexico | MXN |
| VIE:ALC | Vienna | Austria | EUR |
| BOATS:ALC | BOATS | United States | USD |
| Dusseldorf:2U3 | Dusseldorf | Germany | EUR |
| Munich:2U3 | Munich | Germany | EUR |
| Hamburg:2U3 | Hamburg | Germany | EUR |
| Hanover:2U3 | Hanover | Germany | EUR |
| Stuttgart:2U3 | Stuttgart | Germany | EUR |
| BIVA:ALCN | BIVA | Mexico | MXN |
| Turquoise:ALCZ | Turquoise | United Kingdom | CHF |
Valuation
P/E 54.0× against a median of 27.9×: 9th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 32.53B CHF
- P/E
- 54.0×
- EV/sales
- 3.5×
- EV/EBITDA
- 16.1×
- Price/book
- 1.6×
- Gross margin
- 57.7%
- Operating margin
- 10.6%
- Net margin
- 6.1%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Alcon AG · SIX:ALC | US$35.86B | US$38.74B | 54.0× | 3.5× | 16.1× | 1.6× | 6.1% | 0.2× | n/a |
| Boston Scientific Corporation · NYSE:BSX | US$60.85B | US$71.15B | 17.4× | 3.4× | n/a | 2.4× | 16.6% | 0.4× | 0.31 |
| Edwards Lifesciences Corporation · NYSE:EW | US$58.56B | US$54.52B | 57.3× | 8.2× | 33.8× | 5.4× | 15.3% | 0.1× | 0.54 |
| Becton, Dickinson and Company · NYSE:BDX | US$57.96B | US$70.76B | 61.6× | 3.2× | 14.8× | 2.4× | 4.2% | 0.6× | 0.29 |
| Siemens Healthineers AG · XETR:SHL | US$52.77B | US$49.52B | 21.7× | 1.9× | 10.3× | 2.4× | 9.4% | 0.0× | n/a |
| GE HealthCare Technologies Inc. · NASDAQ:GEHC | US$36.46B | US$43.61B | 16.9× | 2.0× | 13.7× | 3.1× | 10.0% | 0.9× | 0.65 |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760 | US$33.43B | US$30.45B | 28.7× | 5.9× | n/a | 5.4× | 22.4% | 0.0× | n/a |
| ResMed Inc. · NYSE:RMD | US$33.14B | US$32.54B | 20.8× | 5.7× | 15.6× | 5.6× | 27.8% | 0.1× | 0.48 |
| DexCom, Inc. · NASDAQ:DXCM | US$29.58B | US$28.62B | 29.9× | 5.6× | n/a | 11.7× | 19.4% | 0.0× | 0.71 |
| Koninklijke Philips N.V. · EURONEXT:PHIA | US$28.31B | US$34.23B | 27.0× | 1.8× | 10.0× | 2.2× | 5.4% | 0.7× | n/a |
| STERIS plc (Ireland) · NYSE:STE | US$24.94B | US$26.30B | 30.2× | 4.3× | 15.8× | 3.4× | 13.4% | 0.3× | 0.40 |
| Median of the others | US$34.95B | US$38.92B | 27.9× | 3.8× | 14.8× | 3.3× | 14.4% | 0.2× | 0.48 |
Forecasts
Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 74.90 CHF · Analysts' mean
- EPS, year to Dec 2026
- 3.51 · 19 analysts
- Revenue, year to Dec 2026
- 11.06B · 11 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| David J. Endicott | Chief Executive Officer |
| Andreas Schuh | Chief Financial Officer |
| Royce Bedward | secretary of the meeting |
| Dan Cravens | Investor Relations |
| Luiza Barros | Investor Relations |
Board
| Director | Role |
|---|---|
| F. Michael Ball | Chairman |
| Arthur Cummings | Board Member |
| David J. Endicott | Chief Executive Officer |
| Deborah Di Sanzo | Board Member |
| Dieter Spälti | Board Member |
| Ines Pöschel | Board Member |
| Karen May | Board Member |
| Keith Grossman | Board Member |
| Lynn D. Bleil | Board Member |
| R. Scott Herren | Board Member |
| Thomas Glanzmann | Board Member |
Events
- Next results
- Feb 23, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Alcon (SIX Swiss: ALC) Q2 2026 Earnings Call | Tue, Aug 11, 2026 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q1 2026 Earnings Call | Wed, May 06, 2026 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q4 2025 Earnings Call | Wed, Feb 25, 2026 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q3 2025 Earnings Call | Wed, Nov 12, 2025 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q2 2025 Earnings Call | Wed, Aug 20, 2025 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q1 2025 Earnings Call | Wed, May 14, 2025 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q4 2024 Earnings Call | Wed, Feb 26, 2025 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q2 2024 Earnings Call | Wed, Aug 21, 2024 · 8:00 AM ET | Replay |
| Alcon (SIX Swiss: ALC) Q1 2024 Earnings Call | Tue, May 14, 2024 · 8:00 AM ET | Replay |
All 29 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 10, 2026 · After close | −3.9% |
| Q2 2026 | Aug 10, 2026 · After close | +4.7% |
| Q1 2026 | May 5, 2026 · After close | −11.0% |
| Q4 2025 | Feb 24, 2026 · After close | +4.4% |
| Q3 2025 | Nov 11, 2025 · After close | +3.8% |
| Q2 2025 | Aug 19, 2025 · After close | −9.4% |
| Q1 2025 | May 13, 2025 · After close | −7.6% |
| Q4 2024 | Feb 25, 2025 · After close | +5.4% |
| Q3 2024 | Nov 12, 2024 · After close | +0.1% |
| Q2 2024 | Aug 20, 2024 · After close | −2.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 13, 2024 · After close | +7.5% |
| Q4 2023 | Feb 28, 2024 | +6.0% |
| Q3 2023 | Nov 14, 2023 · After close | −5.3% |
| Q2 2023 | Aug 15, 2023 · After close | +1.0% |
| Q1 2023 | May 9, 2023 · After close | +7.4% |
| Q4 2022 | Feb 27, 2023 · After close | −4.0% |
| Q3 2022 | Nov 15, 2022 · After close | +5.1% |
| Q2 2022 | Aug 9, 2022 · After close | −6.4% |
| Q1 2022 | May 10, 2022 · After close | +9.2% |
| Q4 2021 | Feb 15, 2022 · After close | +2.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 31 slides | Nov 10, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 31 slides | Aug 11, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 24 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 30 slides | Feb 25, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 24 slides | Jan 13, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 30 slides | Nov 12, 2025 |
| Merger or Acquisition (November 2025) | Merger or acquisition | 23 slides | November 2025 |
| Baird 2025 Global Healthcare Conference | Conference | 16 slides | Sep 9, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 34 slides | Aug 20, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 25 slides | May 14, 2025 |
Show 50 decks
This page holds 50 of 93 decks. Open Decks
Financings
| Raise | Date | In US dollars |
|---|---|---|
| 3.875% senior notes due 2033 Announced: €500M Use of proceeds: General corporate purposes, which may include refinancing existing debts of the Group | Aug 26, 2026 | US$582.7M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.4B | 9.91B | 9.46B | 8.72B | 8.29B | 6.83B | 7.51B | 7.15B | 6.79B | 6.60B |
| Cost of revenue | 4.59B | 4.33B | 4.14B | 3.91B | 3.58B | 3.83B | 3.72B | 3.96B | 3.59B | 3.48B |
| Gross profit | 5.75B | 5.51B | 5.25B | 4.75B | 4.65B | 2.94B | 3.66B | 3.19B | 3.20B | 3.11B |
| Research and development | 990.0M | 876.0M | 828.0M | 702.0M | 842.0M | 673.0M | 656.0M | 587.0M | 584.0M | 499.0M |
| Selling, general and administrative | 3.45B | 3.25B | 3.21B | 3.07B | 3.08B | 2.69B | 2.85B | 2.80B | 2.60B | 2.53B |
| Operating income | 1.36B | 1.41B | 1.04B | 672.0M | 580.0M | -482.0M | -187.0M | -248.0M | -77.0M | 10.0M |
| Depreciation and amortization | 1.33B | 1.23B | 1.22B | 1.12B | 1.22B | 1.62B | 1.43B | 1.64B | 1.30B | 1.29B |
| EBITDA | 2.69B | 2.64B | 2.26B | 1.79B | 1.80B | 1.14B | 1.24B | 1.39B | 1.23B | 1.30B |
| Interest expense | 204.0M | 192.0M | 189.0M | 134.0M | 120.0M | 124.0M | 113.0M | 24.0M | 27.0M | 30.5M |
| Income before tax | 1.16B | 1.26B | 832.0M | 463.0M | 418.0M | -635.0M | -332.0M | -300.0M | -127.0M | -113.0M |
| Income tax | 180.0M | 238.0M | -142.0M | 128.0M | 42.0M | -104.0M | 324.0M | -73.0M | -383.0M | 57.0M |
| Net income | 980.0M | 1.02B | 974.0M | 335.0M | 376.0M | -531.0M | -656.0M | -227.0M | 256.0M | -170.0M |
| Earnings per share, basic | 1.99 | 2.06 | 1.98 | 0.68 | 0.77 | -1.09 | -1.34 | -0.46 | 0.52 | -0.35 |
| Earnings per share, diluted | 1.98 | 2.05 | 1.96 | 0.68 | 0.76 | -1.09 | -1.34 | -0.46 | 0.52 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.53B | 1.68B | 1.09B | 980.0M | 1.57B | 1.56B | 822.0M | 227.0M | 172.0M | 162.0M |
| Short-term investments | 80.9M | 1.00M | 7.00M | 0 | 3.00M | 0 | 33.0M | 31.0M | ||
| Receivables | 1.94B | 1.74B | 1.77B | 1.67B | 1.50B | 1.36B | 1.39B | 1.25B | 1.52B | 1.40B |
| Inventory | 2.39B | 2.27B | 2.32B | 2.11B | 1.90B | 1.64B | 1.50B | 1.44B | 1.30B | 1.21B |
| Current assets | 6.45B | 6.31B | 5.65B | 5.19B | 5.39B | 4.99B | 4.24B | 3.40B | 3.29B | 3.02B |
| Property, plant and equipment | 4.77B | 4.39B | 4.37B | 4.03B | 3.71B | 3.42B | 3.11B | 2.80B | 2.56B | 2.29B |
| Goodwill | 9.26B | 8.95B | 8.93B | 8.93B | 8.90B | 8.90B | 8.90B | 8.90B | 8.89B | 8.89B |
| Total assets | 31.6B | 30.3B | 29.6B | 29.2B | 28.0B | 27.6B | 27.7B | 27.1B | 27.4B | 27.7B |
| Accounts payable | 926.0M | 773.0M | 811.0M | 861.0M | 903.0M | 876.0M | 833.0M | 663.0M | 672.0M | 607.0M |
| Current liabilities | 3.05B | 2.28B | 2.40B | 2.74B | 2.47B | 2.26B | 2.30B | 1.89B | 1.78B | 1.67B |
| Long-term debt | 4.16B | 4.54B | 4.68B | 4.54B | 3.97B | 3.95B | 3.22B | 0 | ||
| Total debt | 4.74B | 4.64B | 4.74B | 4.65B | 4.08B | 4.12B | 3.48B | 47.0M | 149.0M | 275.0M |
| Total liabilities | 9.52B | 8.79B | 8.99B | 9.49B | 8.74B | 8.78B | 8.35B | 4.42B | 4.36B | 4.73B |
| Shareholders' equity | 22.0B | 21.6B | 20.6B | 19.7B | 19.3B | 18.8B | 19.3B | 22.6B | 23.0B | 23.0B |
| Shares outstanding | 496.2M | 497.6M | 496.5M | 494.4M | 493.4M | 489.2M | 488.3M | 488.7M | 488.7M | 488.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.27B | 2.08B | 1.39B | 1.22B | 1.34B | 823.0M | 920.0M | 1.14B | 1.22B | 1.25B |
| Capital spending | -543.0M | -473.0M | -658.0M | -636.0M | -700.0M | -479.0M | -553.0M | -524.0M | -415.0M | -506.0M |
| Free cash flow | 1.73B | 1.60B | 730.0M | 581.0M | 645.0M | 344.0M | 367.0M | 616.0M | 803.0M | 739.0M |
| Cash from investing | -1.34B | -1.17B | -1.09B | -1.86B | -1.20B | -572.0M | -1.01B | -1.00B | -679.0M | -843.0M |
| Cash from financing | -1.12B | -322.0M | -211.0M | -8.00M | -123.0M | 466.0M | 659.0M | -78.0M | -539.0M | -435.0M |
| Dividends paid | -166.0M | -130.0M | -116.0M | -100.0M | -54.0M | 0 | 0 | -54.0M | ||
| Share buybacks | -676.0M | 0 | 0 | -50.0M | -22.0M | -16.0M | ||||
| Change in cash | -149.0M | 582.0M | 114.0M | -595.0M | 18.0M | 735.0M | 595.0M | 55.0M | 10.0M | -123.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Nov 10, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 10, 2026 | Current report | SEC |
| SD · Specialized disclosure | May 15, 2026 | ESG report | SEC |
| 6-K · Report of a foreign issuer | May 5, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 2, 2026 | Current report | SEC |
| 144 · Notice of proposed sale | Feb 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 26, 2026 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Feb 24, 2026 | Current report | SEC |
| 20-F · Annual report | Feb 24, 2026 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 24, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Jan 6, 2026 | Current report | SEC |
| DFAN14A | Dec 9, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Nov 12, 2025 | Current report | SEC |
| DFAN14A | Nov 4, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Aug 19, 2025 | Current report | SEC |
| DEFM14A | Aug 5, 2025 | Meeting notice | SEC |
| 6-K · Report of a foreign issuer | Aug 5, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 28, 2025 | Current report | SEC |
| SD · Specialized disclosure | May 28, 2025 | ESG report | SEC |
| 6-K · Report of a foreign issuer | May 13, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 23, 2025 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Apr 4, 2025 | Current report | SEC |
| DFAN14A | Mar 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 27, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Feb 25, 2025 | Current report | SEC |
| 20-F · Annual report | Feb 25, 2025 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 25, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 12, 2024 | Current report | SEC |
| 144 · Notice of proposed sale | Sep 12, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 12, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 9, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 22, 2024 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Aug 20, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 24, 2024 | Current report | SEC |
| 144 · Notice of proposed sale | Jun 4, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 4, 2024 | Other filings | SEC |
| SD · Specialized disclosure | May 29, 2024 | ESG report | SEC |
| 144 · Notice of proposed sale | May 24, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | May 17, 2024 | Other filings | SEC |
| 6-K · Report of a foreign issuer | May 13, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 5, 2024 | Current report | SEC |
| 144 · Notice of proposed sale | Mar 1, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 29, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 29, 2024 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Feb 27, 2024 | Current report | SEC |
| 20-F · Annual report | Feb 27, 2024 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 27, 2024 | Current report | SEC |
| SC 13G · Big-stake notice | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 1, 2024 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Nov 14, 2023 | Current report | SEC |
| 144 · Notice of proposed sale | Aug 21, 2023 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Aug 15, 2023 | Current report | SEC |
| SD · Specialized disclosure | May 30, 2023 | ESG report | SEC |
| 144 · Notice of proposed sale | May 16, 2023 | Other filings | SEC |
| 144 · Notice of proposed sale | May 11, 2023 | Other filings | SEC |
| 144 · Notice of proposed sale | May 11, 2023 | Other filings | SEC |
| 6-K · Report of a foreign issuer | May 9, 2023 | Current report | SEC |
| 6-K · Report of a foreign issuer | Mar 29, 2023 | Current report | SEC |
| IRANNOTICE | Feb 27, 2023 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Feb 27, 2023 | Current report | SEC |
| 20-F · Annual report | Feb 27, 2023 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 27, 2023 | Current report | SEC |
| SC 13G · Big-stake notice | Feb 23, 2023 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Feb 13, 2023 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2023 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Nov 15, 2022 | Current report | SEC |
| SC 13G · Big-stake notice | Sep 8, 2022 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Aug 22, 2022 | Meeting notice | SEC |
| 6-K · Report of a foreign issuer | Aug 22, 2022 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 9, 2022 | Current report | SEC |
| SD · Specialized disclosure | May 26, 2022 | ESG report | SEC |
| 6-K · Report of a foreign issuer | May 10, 2022 | Current report | SEC |
| 6-K · Report of a foreign issuer | Mar 24, 2022 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 15, 2022 | Current report | SEC |
| 20-F · Annual report | Feb 15, 2022 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 15, 2022 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2022 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Nov 9, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 8, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 17, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 28, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 7, 2021 | Current report | SEC |
| SD · Specialized disclosure | May 21, 2021 | ESG report | SEC |
| 6-K · Report of a foreign issuer | May 4, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 28, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Mar 24, 2021 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 23, 2021 | Current report | SEC |
| 20-F · Annual report | Feb 23, 2021 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 23, 2021 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 16, 2021 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 16, 2021 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Nov 10, 2020 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Sep 10, 2020 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Aug 18, 2020 | Current report | SEC |
| SD · Specialized disclosure | May 29, 2020 | ESG report | SEC |
| 6-K · Report of a foreign issuer | May 18, 2020 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 12, 2020 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 6, 2020 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 7, 2020 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 25, 2020 | Current report | SEC |
| 20-F · Annual report | Feb 25, 2020 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Feb 25, 2020 | Current report | SEC |
| SC 13G · Big-stake notice | Feb 14, 2020 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Jan 10, 2020 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Nov 19, 2019 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 27, 2019 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 20, 2019 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 16, 2019 | Current report | SEC |
| S-8 · Registration statement for employee plans | Apr 10, 2019 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Apr 9, 2019 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 2, 2019 | Current report | SEC |
| SEC ACTION | Mar 22, 2019 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Mar 22, 2019 | Other filings | SEC |
| CERT · Exchange's certificate of listing | Mar 22, 2019 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 22, 2019 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 21, 2019 | Other filings | SEC |
| 20FR12B/A | Mar 21, 2019 | Other filings | SEC |
| 20FR12B/A | Mar 13, 2019 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Mar 11, 2019 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 28, 2019 | Other filings | SEC |
| 20FR12B/A | Feb 28, 2019 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 19, 2019 | Other filings | SEC |
| 20FR12B/A | Feb 7, 2019 | Other filings | SEC |
| 20FR12B/A | Jan 18, 2019 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 27, 2018 | Other filings | SEC |
| 20FR12B/A | Dec 27, 2018 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Dec 10, 2018 | Other filings | SEC |
| 20FR12B | Nov 13, 2018 | Other filings | SEC |
| 15-12B | Apr 21, 2011 | Other filings | SEC |
| SC 13E3/A | Apr 11, 2011 | Other filings | SEC |
| 25-NSE | Apr 11, 2011 | Other filings | SEC |
| S-8 POS | Apr 8, 2011 | Offer document | SEC |
| S-8 POS | Apr 8, 2011 | Offer document | SEC |
| S-8 POS | Apr 8, 2011 | Offer document | SEC |
| S-8 POS | Apr 8, 2011 | Offer document | SEC |
| S-8 POS | Apr 8, 2011 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Apr 7, 2011 | Current report | SEC |
| 6-K · Report of a foreign issuer | Mar 25, 2011 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Mar 24, 2011 | Big-stake notice | SEC |
| 20-F · Annual report | Mar 18, 2011 | Annual report | SEC |
| SC 13D/A · Big-stake notice, amended | Mar 14, 2011 | Big-stake notice | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 28, 2011 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Feb 28, 2011 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 28, 2011 | Current report | SEC |
| SC 13E3/A | Feb 24, 2011 | Other filings | SEC |
| SC 13E3/A | Feb 17, 2011 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 15, 2011 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Feb 15, 2011 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 10, 2011 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 9, 2011 | Big-stake notice | SEC |
| SC 13E3/A | Feb 2, 2011 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Feb 2, 2011 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jan 27, 2011 | Current report | SEC |
| UPLOAD · Letter from the SEC | Jan 21, 2011 | Other filings | SEC |
| SC 13E3 | Dec 23, 2010 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Dec 16, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 15, 2010 | Current report | SEC |
| 425 | Dec 15, 2010 | Other filings | SEC |
| 425 | Dec 15, 2010 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 15, 2010 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Oct 29, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 25, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 25, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 21, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 21, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 12, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 12, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 5, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 1, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 23, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 3, 2010 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 30, 2010 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Aug 26, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 26, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 17, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 17, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 2, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 27, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 27, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 27, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 27, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 19, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 15, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 9, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 8, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 1, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 1, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 28, 2010 | Current report | SEC |
| 11-K · Annual report of an employee plan | Jun 15, 2010 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Jun 2, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 27, 2010 | Current report | SEC |
| UPLOAD · Letter from the SEC | May 25, 2010 | Other filings | SEC |
| 6-K · Report of a foreign issuer | May 21, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 21, 2010 | Current report | SEC |
| CORRESP · Letter to the SEC | May 12, 2010 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 30, 2010 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Apr 28, 2010 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 27, 2010 | Current report | SEC |
This page holds 200 of 528 filings. Open Filings
Cap table
Built by 6ix from Alcon AG’s releases · as of Aug 26, 2026
- Common shares
- 483,400,000
- Fully diluted
- 483,400,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 483,400,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 483,400,000 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| D. Keith Grossman Other companies: MiniMed Group, Inc. (Director · Since at least Mar 6, 2026); Outset Medical, Inc. (Lead Independent Director · Since at least Sep 14, 2020); Nevro Corp (Director · Mar 19, 2019 – Apr 3, 2025 · Past); Zeltiq Aesthetics Inc (Director · Oct 24, 2013 – Apr 28, 2017 · Past); Conceptus Inc (President & CEO · Dec 13, 2011 – Jun 5, 2013 · Past); Kyphon Inc (Director · Apr 24, 2007 – Nov 2, 2007 · Past); Intuitive Surgical, Inc. (Director · May 19, 2006 – Apr 23, 2010 · Past) | Board Member · Since at least May 16, 2026 |
| David J. Endicott Other companies: MiniMed Group, Inc. (Director · Since at least Jun 29, 2026); Zeltiq Aesthetics Inc (Director · Apr 25, 2016 – Apr 28, 2017 · Past); Hospira Inc (Pres., Hospira Medical Devices · Mar 10, 2014 – Sep 3, 2015 · Past); Orexigen Therapeutics Inc (Director · Nov 29, 2012 – Jul 14, 2017 · Past) | Chief Executive Officer · Since at least Aug 10, 2026 |
| F. Michael Ball Other companies: Kythera Biopharmaceuticals Inc (Director · Sep 17, 2013 – Oct 1, 2015 · Past); Hospira Inc (Chief Executive Officer, Director · Mar 28, 2011 – Sep 3, 2015 · Past); Stec Inc (Director · Jun 4, 2007 – Sep 12, 2013 · Past); Intralase Corp (Director · Jul 19, 2006 – Apr 2, 2007 · Past) | Chairman · Since at least May 16, 2026 |
| Allen Trang | Investor Relations · Sep 8, 2025 – Nov 5, 2026 · Past |
| Andreas Schuh | Chief Financial Officer · Since at least Dec 1, 2025 |
| Arthur Cummings | Board Member · Since at least May 16, 2026 |
| Dan Cravens | Investor Relations · Since at least Sep 3, 2026 |
| Deborah Di Sanzo | Board Member · Since at least May 16, 2026 |
| Dieter Spälti | Board Member · Since at least May 16, 2026 |
| Ines Pöschel | Board Member · Since at least May 16, 2026 |
All 19 people
| Person | Seat |
|---|---|
| Karen May | Board Member · Since at least May 16, 2026 |
| Luiza Barros | Investor Relations · Since at least Sep 28, 2026 |
| Lynn D. Bleil | Board Member · Since at least May 16, 2026 |
| Niko Liu | STAAR Investor Relations · Sep 30, 2025 – Nov 5, 2026 · Past |
| Paul Hallen | Chief Operating Officer · Apr 1, 2026 – Nov 5, 2026 · Past |
| Royce Bedward | secretary of the meeting · Since at least May 16, 2026 |
| R. Scott Herren | Board Member · Since at least May 16, 2026 |
| Thomas Glanzmann | Board Member · Since at least May 16, 2026 |
| Thomas Ruggia | President and Chief Executive Officer · Apr 23, 2026 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about Alcon AG.